KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Common Equity (2021 - 2025)

Crescent Capital BDC (CCAP) has disclosed Common Equity for 5 consecutive years, with $714.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 4.64% year-over-year to $714.1 million, compared with a TTM value of $714.1 million through Sep 2025, down 4.64%, and an annual FY2024 reading of $740.6 million, changed 0.26% over the prior year.
  • Common Equity was $714.1 million for Q3 2025 at Crescent Capital BDC, down from $724.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $752.4 million in Q2 2024 and bottomed at $596.2 million in Q3 2021.
  • Average Common Equity over 5 years is $702.6 million, with a median of $725.3 million recorded in 2023.
  • The sharpest move saw Common Equity grew 17.29% in 2023, then decreased 4.64% in 2025.
  • Year by year, Common Equity stood at $652.3 million in 2021, then decreased by 4.55% to $622.6 million in 2022, then increased by 19.27% to $742.6 million in 2023, then fell by 0.26% to $740.6 million in 2024, then fell by 3.59% to $714.1 million in 2025.
  • Business Quant data shows Common Equity for CCAP at $714.1 million in Q3 2025, $724.7 million in Q2 2025, and $727.1 million in Q1 2025.